US CDC expert panel backs use of redesigned Omicron COVID boosters - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

  • 📰 SABCNews
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

Business News News

Business Business Latest News,Business Business Headlines

Advisers to the US Centers for Disease Control and Prevention on Thursday voted to recommend the use of COVID-19 booster shots redesigned to target the BA.4 and BA.5 Omicron subvariants of the coronavirus for people aged 12 years and older.

The CDC’s Advisory Committee for Immunisation Practices voted 13-to-1 in favour of the updated boosters by Pfizer /BioNTech and Moderna.

The FDA authorised the Pfizer/BioNTech shots for people ages 12 and older and the Moderna booster for those 18 and over, if they have received a primary vaccine series or a booster at least two months prior. CDC and FDA officials have said they believe the shots will boost immunity against the virus ahead of the winter season, when infections tend to rise as people spend more time indoors where the virus is more easily transmitted.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 37. in BUSİNESS

Business Business Latest News, Business Business Headlines